ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus

Go back to ABIVAX Expands Its Antiviral Portfolio with Compounds Targeting Zika Virus
(NASDAQ: ABVX) Delayed: 114.95 -3.24 (2.74%)
Previous Close $118.19    52 Week High
Open $117.69    52 Week Low
Day High $120.26    P/E N/A 
Day Low $114.50    EPS
Volume 988,464